Treace Medical Concepts, Inc.
TMCI
$6.72
$0.060.90%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 92.02% | 12.33% | -72.81% | -38.81% | -42.36% |
| Total Depreciation and Amortization | -2.52% | 37.92% | 93.24% | 106.60% | 38.39% |
| Total Amortization of Deferred Charges | 87.28% | -1.33% | 0.00% | 1.35% | 665.33% |
| Total Other Non-Cash Items | 69.50% | 30.40% | 131.12% | 160.67% | 68.16% |
| Change in Net Operating Assets | -1,022.16% | -868.25% | -240.29% | 119.86% | 73.84% |
| Cash from Operations | -890.79% | -24.48% | -66.73% | 58.16% | 109.93% |
| Capital Expenditure | -36.74% | 18.22% | 59.13% | -165.70% | 3.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.48% | 6.52% | 74.99% | 109.73% | 111.76% |
| Cash from Investing | -31.68% | 25.36% | 315.23% | 104.67% | 107.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.98% | -99.90% | -- | -99.95% | -40.07% |
| Repurchase of Common Stock | -138.46% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -84.24% | -94.97% | -73.64% | -100.17% | -44.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -113.32% | -27.62% | 150.33% | -135.98% | 108.26% |